Jason Colquitt remembers the exhaustion he felt playing football in high school. Despite repeated hospitalizations for what was thought to be severe dehydration and rhabdomyolysis—a breakdown of muscle from intense exercise—it was years before anyone considered these episodes as something more serious. It would take a ten-day hospitalization for a doctor to tell him that such episodes were not normal and that testing should be done to determine what was causing his episodes. Seventeen years ago, at the age of 32, he was diagnosed with the rare mitochondrial disorder called carnitine palmitoyltransferase II deficiency.

Jason lives outside Atlanta, Georgia with his wife and four children. He has been blessed to meet and work with many amazing people and organizations during his 20+ years in the healthcare technology field. His work has caused positive disruption within the healthcare industry as he has partnered with many organizations ranging from small start-ups to some of the world's largest health companies including Greenway Health, Walgreens/Boots Alliance, Quintiles, IQVIA, Cystic Fibrosus Foundation, Muscular Dystrophy Association, the American College of Surgeons, and many more.

Today, Jason is CEO of Across Healthcare, which he founded in 2012 to envision, design, and deliver innovative technology solutions to organizations across the healthcare continuum. This includes supporting patient, provider, payor, and life sciences organizations. In January of 2019 while attending the JP Morgan Healthcare Conference, Jason received a clear vision to use his experiences and technical background to help the rare disease community. Thus, Matrix was born. It is Jason’s and Across Healthcare’s hope and desire to use the Matrix platform to help care for and cure rare diseases.